When printing this page, you must include the entire legal notice. This material may not be published, reproduced, broadcast, rewritten, or redistributed without permission. Use of this site constitutes acceptance of our terms and conditions of fair use. Students, members of the community, and users worldwide will find information to assist with many writing projects.
Chemalyze will then broaden the scope of its market strategy to include the medical diagnostics market. This expansion will be achieved through the initial design, development, manufacture and sale of handheld, point-of-care blood and urine analyzers.
Such product development flows from a laboratory process to mass production via the construction of a small scale manufacturing plant known as a pilot plant.
This pilot plant is used for further experimentation and process optimization, before the company completes the conceptual design of the full-scale plant. By adopting Chemalyze's analyzer technology at the pilot plant stage, pharmaceutical companies will realize immediate savings through developing a more efficient design.
These savings will be multiplied in new and existing full-scale plants from both improved efficiencies and reduced reprocessing costs see Primary Market. Chemalyze's technology will also improve project economics for conceptual projects.
This will make larger plants significantly more cost effective and profitable, thus making some projects viable that were previously uneconomical. There is an immediate need where Chemalyze's analyzer technology can be applied: Furthermore, the FDA requires that each facility monitor and document the amount of detergent leftover in the process equipment after each cleanin—referred to as residuals.
These residuals have to be tested to assure that they are not contaminating the final product that is packaged and sold on the market. The current cleaning process requires that the system be shut down and the inside of the tanks swabbed. These swabs are then sent to a laboratory that performs an analysis to determine the amount of residual left in the tank or pipe after cleaning.
This process takes time and requires that the facility be shut down days. Chemalyze can provide a real-time analytical system to monitor the amount of residual left in each plant line, which decreases manufacturing down time and improves plant utilization.
Such improvements can be worth far more than the savings detailed in Primary Market when one takes into account the market value of the final product and the lost opportunity cost associated with failed batches. Furthermore, Chemalyze's technology can be utilized at the end of the process as a final QC for lot release testing to test for any trace elements that may be carried over in the product processing.
In some of our discussions with process plant operators it became clear that there are not only bottlenecks within the process but that there are also bottlenecks at the final QC release test. Strategic Alliances To achieve its vision, Chemalyze will partner with corporations that have distinctive competencies in the development and manufacture of chemical analyzer systems.
Leading liquid process automation and control specialists. These companies can provide1 technical collaboration to enable Chemalyze to develop an analyzer that complements their control systems, 2 capital resources to fund development costs, and 3 well-established distribution channel to pharmaceutical manufacturers.
In return, Chemalyze will become an exclusive supplier of Sensor Cartridges to the selected partner, giving the control specialist a significant competitive advantage in process quality control of complex chemical processes. Major manufacturers of chemical analyzer e. Chemalyze's analyzer will be a complementary product that expands the capabilities of their existing chemical analyzer systems.
Core Competency Chemalyze's core competency is in developing real-time analytical platforms for complex chemical solutions. It is not a high volume instrumentation manufacturer, but rather a company that develops customized analytical sensing technology for different industrial applications.
Hence, when Chemalyze has developed a pre-production prototype analyzer it will license this product to a major instrument manufacturer and will outsource the design and manufacture of the Sensor Cartridges.
However, Chemalyze will continue to develop the Sensor Beads for residuals testing and customized beads for a customer's proprietary chemistries for its clients. Thus, the core of the proprietary Sensor Cartridge technology the Sensor Beads will continue to be developed and manufactured i- house.
See Manufacturing Strategy for further detail. Expansion Strategy into Secondary Markets Chemalyze will exploit its experience in the fine chemicals industry to leverage its technological competence in other markets that can benefit from multi-chemical sensing.
Sensor Cartridges and the Sensor Beads will then be customized for these new markets, again with licensing granted to a large-scale manufacturer when a pre-production prototype analyzer has been developed. Medical diagnostics is a major secondary market for the company due to its need for real-time chemical analysis of complex chemical solutions.
In discussing this opportunity with emergency room physicians and clinical laboratory nurses it has become clear that there is a need for fast response chemical analysis in the emergent care environment to help save lives.
Hospital management will also have a keen interest in Chemalyze's technology, as it will result in significant savings in laboratory overhead costs and the resulting reduction in personnel.
Chemalyze will not only compete on price but will differentiate itself from the current state-of-the-art by offering customized products designed to suit the particular needs of the customer. It complements existing chemical analysis technology.
In the case of HPLC, Chemalyze's analyzer can be adapted to work with existing instrumentation and add to the current analytical methods. Thus, providing a fourth dimension chemical analysis [specific to the chemical s of interest and highly selective].
It will also be developed into a cost-effective, highly accurate handheld instrument for performing medical diagnostics in emergency care environments. Chemalyze will sublicense the analyzer to OEM partners and co-development customers.Professional Services Photography Studio Sample Business Plan.
Starting up your photography studio will need a proper business plan and this sample will provide the guidelines. Business planning is a way of answering, “What problem(s) are we trying to solve?” or “What are we trying to achieve?” but also, “Who will get us there, by when, and how much money and other resources, will it take?” The business planning process takes into account the nonprofit’s mission and vision, the role of the board, and external environmental factors, such as the.
This quick guide offers tips that will help you create the executive summary for your business plan. Writing the Executive Summary of Your Business Plan Here's a suggested format for an. indicates an example drawn from a real-world business in order to Read more about the business plan template..
Writing the Business Plan After the group-planning workshop, the person leading the writing of the plan should Building Block 2 – The Business Plan and Executive Summary.
Free business planning and marketing tips, samples, examples and tools - how to write a business plan, techniques for writing a marketing strategy, strategic business plans and sales plans. OGScapital is the leading consulting company in writing a business plan.
If you need any help, our professional business plan writers and consultants are ready .